BioSpace News Archive

Neuronetics, Inc. announced the granting of inducement awards to twelve new non-executive employees.

The radiation proctitis market is projected to register a favorable CAGR of ~7% during the assessment period, owing to a high prevalence of radiation toxicity.

The US Department of Health and Human Services Secretary Xavier Becerra has declared the monkeypox outbreak to be a public health emergency.

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), announces today it will host a conference call and live webcast on August 11, 2022, at 4:30 p.m. EST to discuss its second quarter 2022 results and provide an update on its clinical pipeline.

Jaguar Health, Inc. announced that, effective August 5, 2022, the Company granted 12,500 restricted stock units to one new employee.

Lexicon Pharmaceuticals, Inc. announced the issuance and sale of an additional 2,526,540 shares of its common stock, par value $0.001, pursuant to the full exercise of the underwriters’ option to purchase additional shares in connection with Lexicon’s previously announced public offering of Common Stock.

Daiichi Sankyo and AstraZeneca’s ENHERTU® has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic HER2 low breast cancer who have received a prior chemotherapy in the metastatic setting or developed disease recurrence during or within six months of completing adjuvant chemotherapy.